{
  "case_id": "Case_11",
  "model_id": "mistralai/mistral-7b-instruct",
  "content": " {\n    \"primary_diagnosis\": {\n        \"name\": \"Hepatotoxicity due to Semaglutide\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"T51.90XA - Other specified drug-induced hepatotoxicity, unspecified\",\n        \"reasoning\": \"The patient started semaglutide 3 weeks ago and presents with symptoms of hepatotoxicity (yellowing of skin and sclera, dark urine, fatigue, shortness of breath, rapid heart rate, and pallor, jaundice, tachycardia, and mild splenomegaly on physical exam)\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Hepatitis B\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"B16.0 - Hepatitis B, acute\"\n        },\n        {\n            \"name\": \"Hepatitis C\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"B17.1 - Hepatitis C, acute\"\n        },\n        {\n            \"name\": \"G6PD Deficiency\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"D51.1 - G6PD deficiency (favism) due to other causes\"\n        }\n    ],\n    \"key_findings\": [\n        \"Jaundice\",\n        \"Tachycardia\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Liver function tests\",\n            \"purpose\": \"Rule out hepatotoxicity and other liver diseases\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Hepatitis B surface antigen (HBsAg)\",\n            \"purpose\": \"Rule out hepatitis B\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Hepatitis C antibody\",\n            \"purpose\": \"Rule out hepatitis C\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"G6PD activity test\",\n            \"purpose\": \"Rule out G6PD deficiency\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Hospitalize the patient for close monitoring\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"N-acetylcysteine\",\n                \"dose\": \"IV 150mg/kg/day in 3 doses for 14 days\",\n                \"route\": \"IV\",\n                \"duration\": \"14 days\",\n                \"rationale\": \"To treat hepatotoxicity\"\n            }\n        ],\n        \"monitoring\": [\n            \"Liver function tests, renal function tests, complete blood count, coagulation profile\",\n            \"Daily\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Hepatology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To manage the hepatotoxicity\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly progressive jaundice\",\n        \"Encephalopathy\"\n    ],\n    \"patient_education\": [\n        \"Inform the patient to avoid alcohol consumption\",\n        \"Inform the patient to inform healthcare providers of any other medications he is taking\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week of discharge\",\n        \"conditions\": \"If symptoms persist or worsen\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"The exact cause of the hepatotoxicity is not yet confirmed\",\n        \"The patient's ethnic background may affect his response to some medications and the possibility of G6PD deficiency\"\n    ]\n}",
  "latency": 7.786948919296265,
  "timestamp": "2025-08-10T01:28:11.226008",
  "cached_at": "2025-08-10T01:28:11.226011"
}